All lobbying filings

ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC)

ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) filed a Q2 report for BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) on July 16, 2026, reporting $60,000 in lobbying income.

Lobbying for BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) · Trade association

All filings by ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) · Everything BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 16, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Defense

BIOSECURE Act/S. Amdt. 3236 to S. 2296, the National Defense Authorization Act for FY2026.

Medicare/Medicaid

Issues related to reimbursement under Medicare Part B and Part D; Most Favored Nation (MFN).

Health Issues

Issues related to drug pricing, generally; 340B Drug Pricing Program; pharmacy benefit managers; drug patents and patent reporting requirements; H.R. 1262/S. 932, Give Kids a Chance Act.

Bills named in this filing 3

S. 2296
National Defense Authorization Act for Fiscal Year 2026
H.R. 1262
Mikaela Naylon Give Kids a Chance Act
S. 932
Give Kids a Chance Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.